News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Mujer de Ubikare atendiendo a paciente con tensiómetro
Ubikare and IKERLAN develop a pioneering infrastructure to transform coordination in home-based care
Healthcare · Digitalization
The ESSAD project will enable the secure sharing of socio-health information among the various…
Partners - UBIKARE
GENESIS Biomed contribuye a la estructuración de estrategias de crecimiento en KYMOS y otras empresas catalanas a través del programa NON ACCIÓ
GENESIS Biomed contributes to the development of growth strategies for KYMOS and other Catalan companies through the NON ACCIÓ programme
Healthcare · Financing · Corporate
ACCIÓ’s Noves Oportunitats de Negoci calls for proposals provide Catalan companies with a…
Partners - GENESIS Biomed
Shilpa Biocare invierte en Gate2Brain para impulsar G2B-002, un innovador candidato terapéutico para el cáncer cerebral
Shilpa Biocare Invests in Gate2Brain to Advance G2B-002, an Innovative Brain Cancer Therapeutic Candidate
Healthcare · Rare diseases · Innovative drugs
Gate2Brain signs a strategic partnership with Shilpa Biocare, including a €7 million investment for…
Partners - Gate2Brain
El Parc Científic de la Universidad de Barcelona alcanza una inversión histórica de 230 millones de euros en 2025
The University of Barcelona Science Park reaches a new investment record of €230 million in 2025
Healthcare · Innovative drugs · Financing
The University of Barcelona Parc Científic de Barcelona (PCB-UB) broke its investment record in…
Partners - Parc Científic de Barcelona
LOGO STABLEPHARMA
Stablepharma and AFT Move to Expand Fridge-Free Vaccine Distribution Following Positive Clinical Data
Healthcare · Innovative drugs · International
Potential agreement follows positive clinical and stability data, supporting rollout in UK, Canada…
Partners - STABLEPHARMA
ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia (AML) at European Hematology Association (EHA) 2026 Annual Congress
ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia (AML) at European Hematology Association (EHA) 2026 Annual Congress
Healthcare · Drug discovery · Innovative drugs
In first line AML (ALICE-2 trial), iadademstat with azacitidine and venetoclax showed high levels…
Partners - Oryzon Genomics
Joan Martí – Director de Estrategia Empresarial en ACCIÓ
Joan Martí: “Corporate culture is a critical factor in M&A and partnership processes”
Financing · Corporate
Joan Martí is Director of Business Strategy at ACCIÓ, the Agency for Business Competitiveness of…
Partners - GENESIS Biomed
VIVEbiotech amplía su cartera con nuevos programas terapéuticos basados en vectores lentivirales in vivo
VIVEbiotech adds newest in vivo lentiviral vector-based therapeutic programs
Healthcare · Innovative drugs · Advanced therapies
Now advancing 15 next-generation in vivo therapies through high performance, scalable lentiviral…
Partners - VIVEbiotech
BCN HEALTH publica un estudio que evalúa la incidencia y el coste asociado al colangiocarcinoma intrahepático en España
BCN HEALTH publishes a study evaluating the incidence and medical cost associated to intrahepatic cholangiocarcinoma in Spain
Healthcare · Innovative drugs · Personalized medicine
Partners - BCN Health